Journal
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY
Volume 11, Issue 1, Pages 36-44Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrgastro.2013.141
Keywords
-
Categories
Funding
- Academy of Finland
- Sigrid Juselius Foundation
- Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital [9P020, 9P033]
- Elna Kaarina Savolainen's fund
- Pediatric Research Foundation
- European Commission IAPP grant TRANSCOM [PIA-GA-2010-251506]
Ask authors/readers for more resources
Coeliac disease is a common and fairly well-characterized systemic disorder that mainly affects the small intestine, but also has extraintestinal manifestations. The environmental trigger (gluten derived from wheat, rye and barley), the genetic predisposition conferred by the HLA-DQ2 and HLA-DQ8 haplotypes and many steps in the disease pathogenesis are known. This knowledge has enabled researchers to suggest novel alternative treatments or adjunctive therapies to the gluten-free diet, which is currently the only available and effective treatment for the condition. This Review focuses on emerging and potential treatment strategies that are based on the current concept of the disease pathophysiology. The search for novel future treatment modes, including nonpharmacological and pharmacological approaches, is also outlined. The potential pitfalls associated with the various research avenues are also discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available